Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Design Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-21
Purchase
2022-03-22
7:28 pm
Design Therapeutics Inc. DSGN William Arsani
Director
25,000 $18.99 $474,680 6,047,629
(Indirect)
View
2022-03-18
Sale
2022-03-22
7:26 pm
Design Therapeutics Inc. DSGN Xu Stella
Director
590,880 $19.07 $11,266,197 4,139,950
(Indirect)
View
2021-08-31
Purchase
2021-09-02
5:06 pm
Design Therapeutics Inc. DSGN William Arsani
Director
40,000 $15.45 $618,000 6,022,629
(Indirect)
View
2021-03-30
Purchase
2021-04-01
6:35 pm
Design Therapeutics Inc. DSGN Jeffries Sean
Chief Operating Officer
3,050 $20 $61,000 3,050
(Indirect)
View
2021-03-30
Purchase
2021-04-01
6:23 pm
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
SR ONE CAPITAL PARTNERS I LP
SR ONE CAPITAL MANAGEMENT LLC
10% Owner
250,000 $20 $5,000,000 5,626,476
(Direct)
View
2021-03-30
Purchase
2021-04-01
6:19 pm
Design Therapeutics Inc. DSGN Xu Stella
Director
10% Owner
10,000 $20 $200,000 4,730,830
(Indirect)
View
2021-03-30
Purchase
2021-04-01
6:18 pm
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
250,000 $20 $5,000,000 5,626,476
(Indirect)
View
2021-03-30
Purchase
2021-04-01
6:17 pm
Design Therapeutics Inc. DSGN LAPPE RODNEY W
Director
5,000 $20 $100,000 97,024
(Direct)
View
2021-03-30
Purchase
2021-04-01
6:16 pm
Design Therapeutics Inc. DSGN Shah Pratik
Chairman
25,000 $20 $500,000 154,923
(Indirect
Direct)
View
2021-03-30
Purchase
2021-04-01
6:14 pm
Design Therapeutics Inc. DSGN Thacker Justin
VP
17,500 $20 $350,000 17,500
(Direct)
View
2021-03-30
Purchase
2021-04-01
6:12 pm
Design Therapeutics Inc. DSGN William Arsani
Director
700,000 $20 $14,000,000 2,732,501
(Indirect)
View
2021-03-30
Purchase
2021-04-01
4:15 pm
Design Therapeutics Inc. DSGN Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Cormorant Private Healthcare Fund III LP
Former 10% Owner
750,000 $20 $15,000,000 5,114,844
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-15
Option Award
2022-06-16
5:17 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN Xu Stella
Director
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:16 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN LAPPE RODNEY W
Director
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:10 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN Schmid John P.
Director
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:08 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN William Arsani
Director
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:07 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:06 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN Prasad Deepa
Director
15,000 $0 15,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:05 pm
N/A
2032-06-14
Design Therapeutics Inc. DSGN Berger Heather A.
Director
15,000 $0 15,000
(Direct)
View
2022-03-16
Other
2022-03-18
5:37 pm
N/A
N/A
Design Therapeutics Inc. DSGN Prasad Deepa
Director
11,806 $0 23,612
(Direct)
View
2022-02-01
Option Award
2022-02-02
7:51 pm
N/A
2032-01-31
Design Therapeutics Inc. DSGN Jeffries Sean
Chief Operating Officer
350,000 $0 350,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
7:50 pm
N/A
2032-01-31
Design Therapeutics Inc. DSGN Shah Pratik
Chairman
475,000 $0 475,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
7:50 pm
N/A
2032-01-31
Design Therapeutics Inc. DSGN Siffert Joao MD
CEO
475,000 $0 475,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
7:49 pm
N/A
2032-01-31
Design Therapeutics Inc. DSGN Burgess Julie
CAO
50,000 $0 50,000
(Direct)
View
2021-10-01
Option Award
2021-10-04
4:53 pm
N/A
2031-09-30
Design Therapeutics Inc. DSGN Burgess Julie
CAO
135,000 $0 135,000
(Direct)
View
2021-08-13
Ownership
2021-08-17
7:21 pm
N/A
N/A
Design Therapeutics Inc. DSGN Giangiulio Dawn
Principal Accounting Officer
0 $0 44,308
(Direct)
View
2021-06-15
Option Award
2021-06-16
5:21 pm
N/A
2031-06-14
Design Therapeutics Inc. DSGN Prasad Deepa
Director
30,000 $0 30,000
(Direct)
View
2021-06-15
Ownership
2021-06-16
5:20 pm
N/A
N/A
Design Therapeutics Inc. DSGN Prasad Deepa
Director
0 $0 1,817,273
(Indirect)
View
2021-06-15
Option Award
2021-06-16
5:17 pm
N/A
2031-06-14
Design Therapeutics Inc. DSGN Behanna Heather
Director
30,000 $0 30,000
(Direct)
View
2021-03-30
Conversion
2021-04-01
6:25 pm
N/A
N/A
Design Therapeutics Inc. DSGN Quan Venture Fund II L.P.
10% Owner
12,415,784 $0 4,720,830
(Direct)
View
2021-03-30
Conversion
2021-04-01
6:23 pm
N/A
N/A
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
SR ONE CAPITAL PARTNERS I LP
SR ONE CAPITAL MANAGEMENT LLC
10% Owner
14,140,132 $0 5,626,476
(Direct)
View
2021-03-30
Conversion
2021-04-01
6:19 pm
N/A
N/A
Design Therapeutics Inc. DSGN Xu Stella
Director
10% Owner
12,415,784 $0 4,730,830
(Indirect)
View
2021-03-30
Conversion
2021-04-01
6:18 pm
N/A
N/A
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
14,140,132 $0 5,626,476
(Indirect)
View
2021-03-30
Conversion
2021-04-01
6:16 pm
N/A
N/A
Design Therapeutics Inc. DSGN Shah Pratik
Chairman
275,948 $0 154,923
(Indirect)
View
2021-03-30
Conversion
2021-04-01
6:12 pm
N/A
N/A
Design Therapeutics Inc. DSGN William Arsani
Director
5,345,479 $0 2,732,501
(Indirect)
View
2021-03-30
Conversion
2021-04-01
4:15 pm
N/A
N/A
Design Therapeutics Inc. DSGN Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Cormorant Private Healthcare Fund III LP
Former 10% Owner
8,729,688 $0 5,114,844
(Indirect)
View
2021-03-25(A)
Ownership
2021-03-30
5:44 pm
N/A
N/A
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
SR ONE CAPITAL PARTNERS I LP
SR ONE CAPITAL MANAGEMENT LLC
10% Owner
0 $0 5,376,476
(Direct)
View
2021-03-25
Option Award
2021-03-29
6:31 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN Xu Stella
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:56 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN William Arsani
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:55 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN Schmid John P.
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:54 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN LAPPE RODNEY W
Director
15,000 $0 15,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
5:52 pm
N/A
2031-03-24
Design Therapeutics Inc. DSGN George Simeon
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-03-25
Ownership
2021-03-25
9:17 pm
N/A
N/A
Design Therapeutics Inc. DSGN SR One Capital Fund I Aggregator LP
10% Owner
0 $0 5,376,476
(Direct)
View
2021-03-25
Ownership
2021-03-25
9:15 pm
N/A
N/A
Design Therapeutics Inc. DSGN Xu Stella
Quan Venture Fund II L.P.
Director
10% Owner
0 $0 4,720,830
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next